Track the Syngene International Limited stock price and the full directors' dealings record of the company, a listed issuer based in India. Shares are listed on IN IN, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Syngene International Limited has published 364 insider filings. Market capitalisation: €291.4bn. The latest transaction was disclosed on 27 December 2024 (Sale). Among the most active insiders: ALOK MEHROTRA. Every trade is free.
364
Insider Decl.
0
Thresholds
€29m
95 ops.
Buy Volume
€508m
267 ops.
Sell Volume
5Σ signal
Buys €29m€508m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 6,577 of 25,484 companies
63.8
score / 100
Value
45
Quality
83
FCF yld1.4%
Earn yld1.7%
EV/EBITDA·
ROE·
Gross mgn73%
Net mgn14%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.